GlassScriptPhysician profile
Carissa M Kasper
NPI 1538655659
$1,239.55
in general payments reported to CMS, 2019-2025
24 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $793 · 2023: $98.43 · 2024: $90.02 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.01 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.22 | 2021-2022 | |
| Biogen, INC. | $97.43 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $78.99 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $71.79 | 2021-2022 | |
| Lilly USA, LLC | $58.14 | 2021-2022 | |
| Glaxosmithkline, LLC. | $58.02 | 2022-2024 | Bexsero, Shingrix, Arexvy |
| Pfizer INC. | $54.93 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.97 | 2022 | |
| Novo Nordisk INC | $36.25 | 2022 | |
| Alfasigma USA, INC. | $33.35 | 2022 | |
| Sanofi-Aventis U.S. LLC | $31.42 | 2022 | |
| Sage Therapeutics, LLC | $30.13 | 2024 | |
| Janssen Pharmaceuticals, INC | $25.66 | 2022 | |
| Amgen INC. | $21.98 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.31 | 2023 | Freestyle Libre 2 |
| Medtronic, INC. | $19.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.59 | 2022 | |
| Hologic Sales and Service, LLC | $18.94 | 2022 | |
| Esperion Therapeutics, INC. | $17.94 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.28 | 2021 | |
| Amarin Pharma, INC. | $14.58 | 2021 | |
| Merck Sharp & Dohme LLC | $14.52 | 2022 | |
| Mayne Pharma Commercial LLC | $9.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.